Glioblastoma Remote Monitoring and Care - Research Protocol

Launched by CASE COMPREHENSIVE CANCER CENTER · Nov 8, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how data collected from an Apple Watch—like walking patterns, heart rate, breathing rate, and sleep habits—relates to the feelings and symptoms of people being treated for glioblastoma, a type of brain cancer. Researchers want to see if the watch can detect changes in a participant’s health before they notice them, which could help in preventing complications. This information could lead to the development of new tools that help doctors monitor patients more effectively.

To be eligible for this study, participants need to be at least 18 years old and have either newly diagnosed or recurrent glioblastoma. They also need to be in relatively good health, which is indicated by a score called the Karnofsky Performance Status (KPS) of 70% or higher. Participants will wear the Apple Watch for most of the day to track their health data and will need to have access to an iPhone to record their symptoms. The trial is currently looking for participants, regardless of gender, who can commit to this monitoring for at least four weeks. This study aims to improve care for glioblastoma patients by using technology to better understand their health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • newly-diagnosed or recurrent glioblastoma undergoing treatment or active surveillance
• • at least 18 years of age at the time of study enrolment
• • Karnofsky Performance Status (KPS) ≥ 70% at time of study enrolment
• • able to comprehend informed consent form and provide informed consent
• • access to patient or caregiver's own Apple iPhone to interface with watch application for documentation of symptoms
• Exclusion Criteria:
• • under 18 years of age at the time of study enrolment
• • inability to give informed consent due to aphasia or other language barrier
• • tattoos located on the skin of the wrist or forearm where the Apple Watch will be placed or other skin conditions preventing adequate sensor function
• • inability to tolerate Apple Watch for at least 12 hours per day on at least 50% of days in a four-week period
• • no access to patient or caregiver Apple iPhone to document symptoms